Time-dependent covariates are often both confounders and intermediate variables. In the presence of such covariates, standard approaches for adjustment for confounding are biased. The method of G-estimation allows for appropriate adjustment. Previous studies applying the G-estimation method have addressed effects on all-cause mortality rather than on specific causes of death. In the present study, a method to adjust for censoring by competing risks is presented. The authors used the approach to estimate the causal effect of isolated systolic hypertension on cardiovascular mortality in the Framingham Heart Study, with a 10-year follow-up using data from 1956 to 1970. Arterial rigidity is a major determinant of isolated systolic hypertension and may be a confounder of the relation between isolated systolic hypertension and cardiovascular death. Conversely, isolated systolic hypertension may by itself contribute to stiffening of the vessel wall, and arterial rigidity may therefore also be an intermediate variable in the causal pathway from isolated systolic hypertension to cardiovascular death. While controlling for arterial rigidity and other baseline and time-dependent covariates, isolated systolic hypertension decreased the time to cardiovascular death by 45% (95% confidence interval 3-69). Am J Epidemiol 1998; 148:390-401. bias (epidemiology); blood pressure; cardiovascular diseases; epidemiologic methods; follow-up studies; models, statistical; statistics Isolated systolic hypertension (ISH) is an established risk factor for cardiovascular disease (1). However, arterial stiffening is the prime cause of ISH and may be associated with an increased cardiovascular risk (2, 3). That means that arterial rigidity may be a confounder of the observed relation between ISH and cardiovascular disease (4, 5). Conversely, high arterial pressure may cause structural changes in the arterial wall and thereby contribute to arterial rigidity (6) (7) (8) effect of ISH on cardiovascular disease. This is a well-recognized problem with time-dependent Cox proportional hazards models (9). The method of Gestimation of structural failure time models is an alternative approach that allows for appropriate adjustment of the effect of an exposure in the presence of time-varying risk factors for death that affect future exposure and are themselves influenced by past exposure (10-17). We used this method to estimate the causal effect of ISH on cardiovascular death in the Framingham Heart Study. Previous studies applying the G-estimation method have addressed effects on all-cause mortality rather than on specific causes of death. In this study, we include a method to adjust for censoring by competing risks. The aim of the paper is twofold: 1) to discuss the main characteristics of the method and 2) to apply the method to data from the Framingham Heart Study. A detailed overview of Gestimation of structural failure time models is provided in reference 17.
Isolated systolic hypertension (ISH) is an established risk factor for cardiovascular disease (1) . However, arterial stiffening is the prime cause of ISH and may be associated with an increased cardiovascular risk (2, 3) . That means that arterial rigidity may be a confounder of the observed relation between ISH and cardiovascular disease (4, 5) . Conversely, high arterial pressure may cause structural changes in the arterial wall and thereby contribute to arterial rigidity (6) (7) (8) . Arterial rigidity may therefore also be an intermediate variable on the causal pathway from ISH to cardiovascular disease. If this is the case, a Cox proportional hazards model that includes the time-dependent covariate arterial rigidity will underestimate the overall effect of ISH on cardiovascular disease. This is a well-recognized problem with time-dependent Cox proportional hazards models (9) . The method of Gestimation of structural failure time models is an alternative approach that allows for appropriate adjustment of the effect of an exposure in the presence of time-varying risk factors for death that affect future exposure and are themselves influenced by past exposure (10) (11) (12) (13) (14) (15) (16) (17) . We used this method to estimate the causal effect of ISH on cardiovascular death in the Framingham Heart Study. Previous studies applying the G-estimation method have addressed effects on all-cause mortality rather than on specific causes of death. In this study, we include a method to adjust for censoring by competing risks. The aim of the paper is twofold: 1) to discuss the main characteristics of the method and 2) to apply the method to data from the Framingham Heart Study. A detailed overview of Gestimation of structural failure time models is provided in reference 17.
MATERIALS AND METHODS The Framingham Heart Study
The Framingham cohort of 2,336 men and 2,873 women, aged 30-62 years at entry, has been exam-
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ined biennially since 1948. The sampling procedure, design, and methods of the study have been presented elsewhere (18) . Data collected at biennial visits include systolic and diastolic blood pressure, use of antihypertensive medication, serum total cholesterol, cigarette smoking, metropolitan relative weight, and diabetes mellitus. We define ISH as a systolic pressure of 160 mmHg or higher, with a diastolic pressure less than 95 mmHg. Diastolic hypertension is defined as a diastolic blood pressure of 95 mmHg or more independent of the level of systolic blood pressure. We use the presence of aortic calcified plaques, as detected on chest radiographs, as a measure of arterial rigidity. Calcified plaques in the aorta are known to represent atherosclerosis (19) , which is a cause of rigidity of the aorta (2, 7) . Previous studies have shown that aortic calcification is a predictor of cardiovascular morbidity and mortality (20, 21) . Roentgenograms of the thorax were routinely taken at biennial examinations. Calcified plaques were diagnosed as present when typically shaped densities were seen in the aortic arch or in the descending part of the thoracic aorta. The scoring was performed at visits 5-10. Aortic calcified plaques were considered present after the first manifestation, even though the plaques might not be visualized on all of the subsequent visits. Participants were monitored for development of cardiovascular disease during followup. The endpoint that is considered in this study is death from cardiovascular disease (primarily myocardial infarction, stroke, and sudden coronary death).
Data description and notation
Exposure status is defined by the presence or absence of ISH and may alternate between visits. Potential confounders considered in this study are cigarette smoking, serum total cholesterol, metropolitan relative weight, diabetes mellitus, and aortic calcification. Confounders measured at or before baseline will be referred to as baseline covariates. Time-dependent levels of the potential confounders will be referred to as time-dependent covariates. Data from visits 5-11 were made available to us. We defined the at risk period (i.e., the follow-up period) to be the period from visits 6 to 11 so the variables available at visits 5 and 6 could be used to adjust for confounding present at the start of the follow-up. The cohort consists of 4,404 subjects alive and with available exposure and covariate information at visit 6. For subjects with missing values at a follow-up visit but with measurements present at subsequent visits, we replaced the missing value with the value from the closest previous visit. During 10 years of follow-up (visits 6-11), 306 subjects died from cardiovascular disease. Visits are denoted by k. ISH,î s the ISH status of subject i at visit k. A similar notation is used for the covariates. For any timedependent variable, we use overbars to denote the history of that variable up to and including k. For example, ISH a = (ISH a , ISH a _j, ISH a _ 2 , and so on). We assume that ISH status at k remains unchanged for the interval (k, k + 1). We use ISH/0 to refer to ISH status at some time / between visits. With ISH,(r), we refer to the history of ISH up to t. A subject's failure time is denoted by T it measured in visit units since visit 6. One visit unit equals 2 calendar years.
The method of G-estimation
To define the causal effect of an exposure, we assume the presence of counterfactual failure times. Following Robins and coauthors (10-17), we assume that for each individual there exists a set of unobserved failure times, each corresponding to a defined exposure history. These failure times are counterfactual because they represent outcomes under circumstances that may not have actually occurred. A causal effect is defined in terms of a comparison of counterfactual failure times associated with different exposure histories. Specifically, we are interested in the comparison of the counterfactual failure times corresponding to the exposure history always exposed and the counterfactual failure times corresponding to the exposure history never exposed.
We define the counterfactual failure time £/, to be the time to failure if subject i is never exposed. In our study, never exposed means never having had ISH. In the next section we will describe a model that relates Uj to observed exposure history and observed failure time. Subsequently, we show how we estimate the model parameter and how this parameter relates to our causal parameter of interest. Counterfactual failure times can only be computed for subjects with an observed failure time. For pedagogic reasons, we first discuss the G-estimation method in the absence of censoring. This would apply to studies in which the outcome of interest is all causes of death and the cohort is followed to extinction.
A model for the counterfactual failure time. We define a failure time model that relates a person's counterfactual failure time, V t , to his observed exposure history and observed failure time, as proposed by Cox and Oakes (22) and by Robins and coauthors (10) (11) (12) (13) (14) (15) (16) (17) . In the present study, U ( is the time to failure if individual i never had ISH. Like T h £/, is measured in visit units since visit 6. A model that relates £/, to the observable data (T it ISH/7V)) is ,). Hence, t|/ 0 = 0 corresponds to the null hypothesis that exposure has no effect. To understand the implications of the model when I//Q is not 0, we have to consider another counterfactual failure time, the failure time that corresponds to continuous exposure. Our model implies that this counterfactual failure time can be obtained by multiplying the counterfactual failure time if never exposed (£/,) by the factor exp(-1// 0 ). That is, a subject's unexposed lifetime U { is expanded or contracted by the factor exp(-1// 0 ) because of continuous exposure. If t// 0 > 0, exposure decreases survival, and if i// 0 < 0, exposure increases survival. In previous papers, this model is called the strong version of the time-dependent accelerated failure time model or the rank-preserving structural failure time model (15, 22) .
Estimation of the exposure effect. In this section, we discuss how we estimate the true value of t// 0 . Fundamental to the approach is the assumption of no unmeasured confounders. We say that there are no unmeasured confounders when, conditional on past ISH and recorded covariate history, subjects with and subjects without ISH at visit k would have the same survival if, possibly contrary to fact, they had never been exposed. Consequently, under the assumption of no unmeasured confounders, ISH at k is independent of U ( given the recorded past. To test this independence, we postulate a model for the probability that an individual has ISH at k given past ISH and covariate history. Define logistic model equals 0: for k = 6, 7, ..., 10,
value of ty, £/,(<//) can be computed from the data (7 1 ,, ISH,(r,)). If equation 1 is correctly specified, and assuming no unmeasured confounders, if i|/ equals the true value i// 0 , then the true value of 6 in the following
,W. (3)
Here, h ik is a vector consisting of all baseline and time-dependent covariates up to and including k, W, j/t is a vector of functions of (ISH,-)fc _,, L I/t ), and a k , fi, and 9 are unknown parameter vectors. We test the hypothesis that a particular value of i// equals i// 0 by testing whether 6 = 0 in equation 3 using a score, Wald statistic, or likelihood ratio test. We refer to any such test of the hypothesis ijj = ij/ o as a G-test. Our G-estimate ijj of i// 0 is the value of t// for which our G-test of the hypothesis 9 -0 is 0. Equivalently, t / > is the value of \\> for which our G-test has a p value = 1. In fitting the model, we pool over all visits k\ that is, each individual contributes multiple observations, one for each time k the subject is alive. The variance a 2 of our point estimate, t//, can be consistently estimated by squaring the inverse of the estimate of the slope of our G-test statistic Z(ip) evaluated at ip (23) . A 95 percent confidence interval can be constructed by the Wald statistic, using the estimated variance, a 2 , or by a test-based method. The test-based 95 percent confidence interval for ip 0 consists of those values of ip for which a G-test of 6 = 0 fails to reject at a 5 percent level (13) . Conceptually, the G-estimation procedure checks, at each successive time k, for an association between ISH status at k and the hypothesized value i/,-(i/0 of the true but unknown counterfactual failure time £/,-, 1) after adjusting for exposure and covariate history before k, but 2) without adjusting for covariate status subsequent to k. By separately examining ISH status at each successive time k, the G-estimation procedure succeeds in controlling confounding by intermediate variables.
Censoring by end of follow-up. In this section, we suppose there is no censoring by competing risks; that is, we consider all causes of death. However, we allow censoring by end of follow-up. We define the potential censoring time at end of follow-up, C,, as the time from the baseline visit (visit 6) to a predefined end of follow-up time (visit 11). Thus, in our data, C, equals five visit units for all subjects. In the above, the counterfactual failure time, U t (ty), can only be computed for uncensored individuals. We shall therefore replace U,{\}/) in equation 3 by a function of f/ ( (i//) and C, which is observed for all subjects. The rationale is that, if Ui is independent of ISH, *. given past ISH and covariate history, the same should be true for any function of £/, and C, (since C, is a baseline covariate). 
where C,(t//) = C, if t// > 0 and C,((//) = C, * exp(<//) if t// < 0. With this definition of C,-(i/0, we obtain that when a subject is censored (7, > C,), f/,(«/') > Q(i/0, so A ( (i//) is always observed. Furthermore, A,(i//) is a function only of U^ifj) and C,. When A,(i//) = 0, we say an individual is i/z-censored. To generate our estimates, we would like to use a simple function with good power. The function A,(t//) satisfies this criterion; that is, we will replace £/,(<//) with 1 for individuals not i//-censored and with 0 for those (//-censored. Indeed, in our data, the use of A/i/r) gave better power than the alternative choices X,-
Censoring by competing risks. In the previous section, we considered the case in which the only type of censoring is censoring by end of follow-up. We will now discuss how we deal with censoring by competing risks when our endpoint of interest is death from cardiovascular disease. Let us for the moment assume that the only cause of censoring other than end of follow-up is death from other causes. We assume that we have data on a sufficient number of confounding factors so that, conditional on these covariates, censoring due to competing risks (i.e., death from other causes) is independent of the time to cardiovascular death. We then specify a model for the censoring process. We specify a logistic model for the probability of death from other causes in the interval (k, k + I), given being alive at k, and with death from cardiovascular disease considered as a censoring event. The model is of the form: for k -6, 7, . . . 10,
Here, T t is redefined as time to death from cardiovascular disease, D, is the time to death from other causes, L,^ is a vector consisting of all baseline and timedependent covariates up to and including k, W* ik is a vector function of (ISH /yt , h ik ), and a* and /3* are unknown parameter vectors. Because the probability of being censored by competing risks between k and k + 1 is small, the logistic model will lead to parameter estimates close to those obtained by a continuous time Cox proportional hazard model (24) . For each subject who does not suffer death from other causes, we use equation 5 to estimate the cumulative probability K t of being free from competing risks through the last visit (time to death from cardiovascular disease or end of follow-up). Our estimates, K i of the probability Kj, are obtained by multiplying the estimated conditional probabilities of being free from competing risks in each 2-year interval prior to a subject's last visit. We then further modify our G-estimation procedure by replacing A,(i//) (which was substituted for £/,((//) in equation 3) by A,(<//)/ K ( if a subject is uncensored by competing risks and by 0 if a subject is censored by competing risks. An intuitive explanation is given here. Given the correctness of our assumption of conditionally independent censoring by competing risks, the following will be true: for each person with a cumulative probability of 25 percent of being free from death by competing risks through the last visit, there would, on average, have been three other persons who were censored by competing risks before or at the last visit, but who would have had a similar set of covariates and risk of cardiovascular death, had censoring been prevented. We therefore assign this person a weight of four in the G-estimation by multiplying his covariate A,(i//) by the factor four.
In the present study, we have to consider other causes of censoring by competing risks. Our goal is to learn what the effect of ISH is on death from cardiovascular disease when diastolic blood pressure in the population is normal and antihypertensive medication is not given. To do so, subjects who develop diastolic hypertension or start antihypertensive treatment must be regarded as censored by competing risks at the time they reach one of these conditions. Specifically, we fit a polytomous logistic regression model with death from other causes and the development of diastolic hypertension or start of antihypertensive treatment as outcome events to obtain estimates of the conditional probability of being free from all censoring events. We then compute the cumulative probability K ( and modify our G-estimation procedure by weighting by the inverse of K h as described above. Furthermore, we no longer regard subject / as an observation at visit k if subject i is censored prior to visit k, that is, subject i has developed diastolic hypertension or started antihypertensive treatment or died.
In the presence of competing risks, our G-estimate \p is still a consistent, asymptotically normal estimator. However, our confidence intervals are no longer valid because 1) the subject-specific contributions to the G-test statistic from two different visits are now correlated and 2) we have used an estimate k t rather than the true, but unknown, K ( . However, it follows from results on pages 284 and 285 of reference 14 and the Appendix of reference 17 that conservative 95 percent large-sample confidence intervals (i.e., intervals guaranteed to cover t// 0 at least 95 percent of the time) can Am J Epidemiol Vol. 148, No. 4, 1998 be obtained by 1) regarding the exposure variables ISH I/fc for a given subject i as clustered (i.e., correlated) binary data and 2) constructing a G-test of the hypothesis 6 = 0 in equation 3 using the robust Wald test outputted by a generalized estimating equations (GEE) software package for clustered binary data using the independence working covariance matrix option (25) . In the presence of censoring, one will usually obtain better and shorter confidence intervals by using the Wald rather than test-based intervals when the data set is relatively small. This is due to loss of information caused by artificial censoring for large positive or negative values of i//. i// 0 and the causal rate ratio. The expansion factor exp(-)// 0 ) is related to a common parameter of public health interest. Specifically, 1 -exp(-t// 0 ) is the fractional decrease in life due to continuous exposure. Greenland and Robins (26) have argued that measures of change in life expectancy are often of greater public health interest than rate ratio measures. However, because the rate ratio is commonly used in epidemiology, we will characterize the relation between i// 0 and the causal rate ratio. We define the causal rate ratio as the mortality rate if all subjects were exposed from baseline onward divided by the rate when all subjects were unexposed throughout. The relation depends on the shape of the distribution of [/,-. If the underlying distribution of U t is Weibull, that is, P(U t > f) -exp(-{\t} K ), the causal rate ratio equals exp(Kt// 0 ). For subjects who reach end of follow-up without failing (T t > C t ), we take C,(t// 0 ) as their time of censoring by end of follow-up, assuming independence of £/, and C,. The parameter K will be estimated using maximum likelihood. Subjects who are censored by competing risks are not included in the estimation procedure. However, information from subjects censored by competing risks will be used by weighting the estimation procedure; the contribution to the log likelihood of each included subject i is weighted by the inverse of the probability, K t , of being free from competing risks.
RESULTS

Evaluation of time-dependent confounders
We first examined the data for time-dependent confounders. We have time-dependent confounders if 1) a subset of the time-dependent covariates are predictors of the hazard of death by cardiovascular disease at any time t, controlling for past ISH history and baseline covariates, and 2) a subset of the time-dependent covariates predict ISH at some visit k, given past ISH history and baseline covariates. We used the timedependent Cox proportional hazards model to examine whether covariate status before t was related to the hazard of cardiovascular death at t, conditional on past ISH and baseline covariate status. Cigarette smoking, serum cholesterol, metropolitan relative weight, diabetes mellitus, and aortic calcification were evaluated as time-dependent covariates. The main predictors of cardiovascular death are given in table 1. The risk of death was significantly related to diabetes mellitus at the preceding visit (visit k). Diabetes mellitus at visits before k was not a significant predictor of death after adjustment for diabetes mellitus at k. The association of cardiovascular death with aortic calcification increased with increasing time period between death and first occurrence of calcification. Borderline significant associations of cardiovascular death with aortic calcification at visits before k were still present after adjustment for more recent measurements. No significant associations were observed between cardiovascular death and other time-dependent covariates.
We used a logistic model, pooling over all visits k (i.e., visits 6-10), to examine whether timedependent covariates predicted ISH at k, conditional on past ISH and baseline covariate status. We assumed that only levels of covariates measured through k -1 were prior to the assessment of ISH at k, and so covariates at visit 5 were treated as baseline covariates. Subjects were censored when they developed table 2 . Aortic calcification at k -1 was a predictor of ISHfc. Aortic calcification at previous visits was not significantly associated with ISH^. after adjustment for the most recent measurement preceding ISH. Diabetes mellitus at k -1 had a weak, nonsignificant association with ISH^.. We next examined whether the occurrence of aortic calcification was predicted by ISH. We used a pooled logistic model to assess the probability of aortic calcification at & as a function of baseline ISH, conditional on baseline covariates, absence of diastolic hypertension or antihypertensive treatment at baseline, and absence of aortic calcification at k -1. The relative risk associated with baseline ISH was 1.25 (95 percent confidence interval 0.98-1.60). Thus, the time-dependent covariate aortic calcification is an independent risk factor for cardiovascular death, predicts future ISH status, and is predicted by previous status of ISH.
Modeling of censoring by competing risks
We next modeled censoring by competing risks. During follow-up, 277 subjects died from causes other than cardiovascular disease. Diastolic hypertension or use of antihypertensive treatment was present in 1,146 subjects at baseline and occurred in 590 during followup. We modeled the probability of death from other causes and the probability of the development of diastolic hypertension or start of antihypertensive treatment in the interval (k, k + 1) as functions of visit number (indicator variables), age, sex, the five baseline covariates and the time-dependent covariates and blood pressure status at k. Figure 1 gives the probabilities of being free from censoring events through the last visit ( k t ) for subjects who died from cardiovascular disease and subjects censored by end of followup. Probabilities could not be computed in 2 percent of subjects because of missing covariate status due to loss to follow-up. These subjects were excluded from the G-analysis.
G-estimation
Among subjects not censored by competing risks, 113 died from cardiovascular disease during followup. For these subjects, we obtained values of C/,-(i//) by equation 2. We used hypothesized values of i// ranging from -3.0 to 3.0. On the basis of U t (ip) and C,, we obtained values of A,(t//) by equation 4 for subjects who died from cardiovascular disease or were censored by end of follow-up. We next computed A,(<//)/ k ( for these subjects and substituted this function for U t (ip) in equation 3. Using generalized estimating equations, we ran three models for the probability of ISH at k of the form of equation 3. Model 1 included only past history of ISH, entered as ISH 5 and lSH k _, age, sex, and A,(t//)/ K t . Model 2 also included the five baseline covariates measured at visit 5. In model 3, we included the baseline covariates and the timedependent covariates at k -1. Aortic calcification at visits before k -1 did not predict ISH^ after adjustment for aortic calcification at k -1. Therefore, controlling for aortic calcification at k -1 will adequately control for time-dependent confounding by aortic calcification. In the presence of time-dependent confounders, model 3 should provide an unbiased estimate under our assumptions. time-dependent covariates are included. Essentially identical intervals were obtained when we used the nonrobust Wald test computed by a standard logistic regression software package for nonclustered data, implying that the effect of within-subject correlation was small in these data.
The causal rate ratio
We obtained the causal rate ratio from i// 0 and the shape of the distribution of £/,-. To generate [/" we used our estimate of ip 0 , 0.60. Figure 3 is a KaplanMeier plot of log P(U; > t) versus time. Inspection of the graph suggests a Weibull distribution with parameter K > 1. The point estimate of K was 1.21 (95 percent confidence interval 1.15-1.28). For this distribution of U { , a i// 0 of 0.60 corresponds to a causal rate ratio of 2.07.
DISCUSSION
In the present study, we used the method of Gestimation to assess the causal effect of ISH on cardiovascular death. We estimated that ISH decreased the time to cardiovascular death by 45 percent (95 percent confidence interval 3-69). Control for timedependent covariates did not change the risk estimate. Apparently, the magnitude of time-dependent confounding in our study was small. The presence of calcified plaques in the aorta may be a poor marker of arterial rigidity. New methods for the noninvasive measurement of arterial stiffness have recently been developed (27) . However, measurements over time are not yet available in epidemiologic studies. A stronger association was found for diabetes mellitus with cardiovascular death, but the association of the timedependent covariate with ISH was weaker and nonsignificant. We could have evaluated the magnitude of confounding by standard methods first. However, the best way to examine the consequence of ignoring confounders is to use a method of analysis, such as the G-estimation procedure, that is valid when adjusting for them.
The inference from our analyses is dependent on several assumptions. The first assumption is that the failure time model correctly links an individual's observed failure time and observed ISH history with his unobserved counterfactual failure time, £/,. In this study, we specified only a simple model. If we do not consider this to be appropriate, we could use a different specification of the model. For example, we could have included ISH /t _ 1 instead of current ISH if we think that ISH status in the interval before current ISH affects cardiovascular death, or we could have included cumulative exposure. Model specification is discussed in more detail by Robins et al. (11, 13, 17) .
Second, to test independence of ISH, k and £/,-, subjects with and subjects without ISH need to be comparable at k. This means that we must have available, at each visit k, data on the history of all timedependent covariates that are risk factors for death and predict the probability of ISH at k (the condition of no unmeasured confounders). Whether this is true cannot be tested by the data. In this study, we assume that this goal has been realized, while recognizing that, in practice, this would never precisely or sometimes even approximately be true.
In the present study, a method to adjust for censoring by competing risks is presented. In our Gestimation procedure, we used weights equal to the inverse of the modeled probability of being free from censoring events through the last visit. We assumed that we had enough information on confounders so counterfactual survival time that censoring by competing risks is independent of the time a subject would have died from cardiovascular disease had censoring been prevented. Missing data and loss to follow-up can be treated in a similar way, that is, by specifying a failure time model with failure being the first time for which complete data are unavailable. In the present analysis, missing values at intermediate visits were replaced with values from the closest previous visit. Missing values due to loss to follow-up were present in a small percentage of subjects, and we excluded these subjects from the analysis. Some aspects of the G-estimation procedure may be of concern when actually applying the method. Our method of dealing with censoring by end of follow-up artificially censors some subjects with an observed failure time. This did not affect inference in our study, although it may do so in smaller data sets. Nevertheless, the use of artificial censoring is necessary to avoid bias under our assumptions. The method to handle censoring is further complicated in that alternative functions of £/, (<W> ISH /jJt , L ik , and A,-(#) can be used to replace t/,-CW m equation 3 (15) . We used the simplest function with good power, A,(</0, but we could have used other functions as well. There is an optimal function that minimizes the variance of our G-estimate (11) . However, this is a complicated function of the joint distribution of the observed failure times and exposure and covariate histories. As such, estimation of the optimal function would be computationally quite complex. The theory of G-estimation requires data on actual, ungrouped, failure times. Use of grouped failure times, by assuming that any death in Am J Epidemiol Vol. 148, No. 4, 1998 the interval (k, k + 1) occurred at k + 1, often results in loss of monotonicity of the graph of Z(i//) versus 4>-Finally, as discussed in Materials and Methods, in the presence of competing risks, it is necessary to use a GEE software package to obtain conservative confidence intervals.
In summary, we estimated the effect of ISH on cardiovascular death under the assumptions specified in this paper. The G-estimation procedure allows for appropriate adjustment of the effect of a time-varying exposure in the presence of time-dependent confounders that are themselves influenced by the exposure.
With an expanding body of data on time-dependent exposures and covariates, we think that situations meeting the above conditions will be increasingly encountered in epidemiologic research.
